Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 8 of 8 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park | |
Company Biogen (Oral Solid Dose Facility) | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. | Location Research Triangle Park | |
Company CSL Seqirus | Activity: Production and Manufacturing | Company Description Seqirus manufactures influenza vaccines using both egg-based and cell-based technologies. | Location Holly Springs | |
Company KBI Biopharma Inc. (Corporate HQ) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. | Location Durham | |
Company Merck & Co. Inc. (Durham) | Activity: Production and Manufacturing | Company Description Merck manufactures vaccine products at its Durham facility. | Location Durham | |
Company Merck & Co. Inc. (Wilson) | Activity: Production and Manufacturing | Company Description Merck's Wilson facility produces patented prescription products and performs granulation and tableting operations. | Location Wilson | |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham | |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton |